Eye and Behcet's disease;CEil et maladie de Behcet

Revue du Praticien

Volumn 49, Issue 18, 1999, Pages 1999-2003

  Binisti, Philippe ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; ANTIGOUT AGENT; HLA B ANTIGEN; HLA BW51; HLA-BW51;

ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OPHTHALMOSCOPY; PREVALENCE; PROGNOSIS; UVEITIS; VISUAL ACUITY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EYE DISEASE; FEMALE; FLUORESCENCE ANGIOGRAPHY; IMMUNOLOGY; IRIDOCYCLITIS; MALE; RECURRENT DISEASE;

ADRENAL CORTEX HORMONES; BEHCET SYNDROME; COLCHICINE; DIAGNOSIS, DIFFERENTIAL; EYE DISEASES; FEMALE; FLUORESCEIN ANGIOGRAPHY; GOUT SUPPRESSANTS; HLA-B ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROGNOSIS; RECURRENCE; UVEITIS, ANTERIOR; UVEITIS, POSTERIOR;

EID: 0033571057     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Michelson JB, Chisari FV. Behçet's disease. Surv Ophthalmol 1982; 26 : 190-203.
2. El Belhadji M, Hamdani M, Laouissi N, Zaghloul K, Amraoui A, Benamour S. L'atteinte ophtalmologique dans la maladie de Behçet. À propos de 520 cas. J Fr Ophtalmol 1997; 20 : 592-8
3. Cochereau-Massin I, Wechsler B, Le Hoang P et al. Pronostic oculaire de la maladie de Behçet. J Fr Ophtalmol 1992; 15 : 343-7
4. Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997; 104 : 701-5
5. Feutrie ML, Hachulla E, Hatron PY et al. Maladie de Behçet Aspect comparatif des critères diagnostiques. Presse Med 1994; 23 : 1809-12
6. Nussenblatt RB. Uveitis in Behçet's disease. Int Rev Immunol 1997;14:67-79
7. Kim HB. Ophthalmologic manifestation of Behçet's disease. Yonsei Med J 1997; 38 : 390-4
8. Dominguez LN, Irvine AR. Fundus changes in Behçet's disease. Trans Am Ophthalmol Soc 1997; 95 : 367-82.
9. Graham EM, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 patients with idiopathic retinal vasculitis : I. Diagnostic value of ophthalmological features. Br J Ophthalmol 1989; 73 : 714-21.
10. Inagaki M, Harada T, Kiribuchi T, Ohashi T, Majima J. Subfoveal choroidal neovascularization in uveitis. Ophthalmologica 1996; 210 : 229-33.
11. Garcher C, Bielefeld P, Desvaux C, Besancenot JF, Bron A. Bilateral loss of vision and macular ischemia related to Behçet disease. Am J Ophthalmol 1997; 124 : 116-7.
12. Atmaca LS, Batioglu F, Idil A. Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation. Graefes Arch Clin Exp Ophthalmol 1996; 234 (2) : 94-9.
13. Masal H, Kashii S, Kimura H, Fukuyama H. Neuro-Behçet disease presenting with internuclear ophthalmoplegia. Am J Ophthalmol 1996; 122 : 897-8.
14. Matsuo T, Sato Y, Shiraga F, Shiragami C, Tsuchida Y. Choroidal abnormalities in Behçet's disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology 1999; 106 : 295-300.
15. Charteris DG, Champ C, Rosenthal AR, Lightman SL, Behçet's disease : activated T lymphocytes in retinal perivasculitis. Br J Ophthalmol 1992; 76 : 499-501.
16. Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996; 55 : 128-33.
17. Mizuki N, Inoko H, Ando H et al. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol 1993; 116 : 406-9.
18. Ota M, Mizuki N, Katsuyama Y et al. The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet 1999; 64 : 1406-10.
19. Wallace GR, Verity DH, Delamaine LJ et al. MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics 1999; 49 : 613-7.
20. th international conference on Behçet disease. In : Godeau P, Wechsler B (eds). Behçet disease. Amsterdam. Elsevier Science Publishers, 1993 : 619-22.
21. Pivetti-Pezzi P, Accorinti M, La Cava M, Catarinelli G, Abdulaziz MA. Ocular features of Behçet disease in Italy. In: Godeau P, Wechsler B (eds). Behçet Disease. Amsterdam. Elsevier Science Publischers, 1993 : 615-8.
22. Nishiura K, Kotake S, Ichiishi A, Matsuda H. Familial occurrence of Behçet's disease. Jpn J Ophthalmol 1996; 40 : 255-9.
23. Yazici H, Barnes CG. Practical treatment recommendations for pharmacotherapy of Behçet's syndrome. Drugs 1991; 42 : 796-804.
24. Celik G, Kalaycioglu O, Durmaz G. Colchicine in Behçet's disease with major vessel thrombosis. Rheumatol Int 1996; 16 : 43-4.
25. Reed JB, Morse LS, Schwab IR. High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis. Am J Ophthalmol 1998; 125 : 409-11.
26. Ozyazgan Y, Yurdakul S, Yazici H et al. Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome : a single masked trial. Br J Ophthalmol 1992; 76 : 241-3.
27. Yazici H, Pazarli H, Barnes CG et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990; 322 : 281-5.
28. Hamuryudan V, Ozyazgan Y, Hizli N et al. Azathioprine in Behçet's syndrome : effects on long-term prognosis. Arthritis Rheum 1997; 40 : 769-74.
29. Georgiou S, Monastirli A, Pasmatzi E, Gartaganis S, Gœrz G, Tsambaos D. Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease. J Intern Med 1998; 243 : 367-72.
30. Kotter I, Eckstein AK, Stubiger N, Zierhut M. Treatment of ocular symptoms of Behçet's disease with Interferon alpha2a : a pilot study. Br J Ophthalmol 1998; 82 : 488-94.
31. Mochizuki M, Masuda K, Sakane T et al. A clinical trial of FK506 in refractory uveitis. Am J Ophthalmol 1993; 115 : 763-9.
32. Kilmartin DJ, Forrester JV, Dick AD. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm 1998; 6 : 101-9.
33. Cataract surgery and intraocular lens implantation in patients with Behçet's disease. Nippon Ganka Gakkai Zasshi 1999; 103 : 119-23.
34. Sakamoto M, Akazawa K, Nishioka Y, Sanui H, Inomata H, Nose Y. Prognostic factors of vision in patients with Behcet disease. Ophthalmology 1995; 102 : 317-21.
35. International study group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335 : 1078-80.